Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM

To the Board of Directors of

Biostar Pharmaceuticals, Inc.

We hereby consent to the incorporation by reference of our report dated March 27, 2012 (except for Note 6 to the consolidated financial statements which is as of April 11, 2013) with respect of the consolidated financial statements of Biostar Pharmaceuticals, Inc. as of and for the year ended December 31, 2011 into the annual report on the Form 10-K of Biostar Pharmaceuticals, Inc. for the year ended December 31, 2012, which report will be filed with the U.S. Securities and Exchange Commission on April 15, 2013.

/s/  Mazars CPA Limited                 

Mazars CPA Limited

Certified Public Accountants

Hong Kong

April 11, 2013